Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356462/
https://www.ncbi.nlm.nih.gov/pubmed/37476733
http://dx.doi.org/10.1155/2023/9837208
_version_ 1785075280719642624
author Healthcare Engineering, Journal of
author_facet Healthcare Engineering, Journal of
author_sort Healthcare Engineering, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10356462
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103564622023-07-20 Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-07-12 /pmc/articles/PMC10356462/ /pubmed/37476733 http://dx.doi.org/10.1155/2023/9837208 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Healthcare Engineering, Journal of
Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
title Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
title_full Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
title_fullStr Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
title_full_unstemmed Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
title_short Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
title_sort retracted: comparison of clinical effects of temozolomide single agent and combined doxorubicin in the treatment of glioma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356462/
https://www.ncbi.nlm.nih.gov/pubmed/37476733
http://dx.doi.org/10.1155/2023/9837208
work_keys_str_mv AT healthcareengineeringjournalof retractedcomparisonofclinicaleffectsoftemozolomidesingleagentandcombineddoxorubicininthetreatmentofglioma

Ejemplares similares